Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization

Journal of Infectious Diseases

Volumn 177, Issue 5, 1998, Pages 1155-1161

  Gallichan, W Scott ^b   Rosenthal, Kenneth L ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES VACCINE; RECOMBINANT ADENOVIRUS GLYCOPROTEIN ADGB8; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE GENITAL TRACT INFECTION; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION PREVENTION; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; PRIORITY JOURNAL; SURVIVAL RATE; VIRUS EXPRESSION; VIRUS IMMUNITY;

EID: 0031899819     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515286     Document Type: Article

References (15)

1. Mestecky J, Kutteh WH, Jackson S. Mucosal immunity in the female genital tract: relevance to vaccination efforts against the human immunodeficiency virus. AIDS Res Hum Retroviruses 1994;10:S11-20.
2. Murphy BR. Mucosal immunity to viruses. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of mucosal immunology. San Diego: Academic Press, 1994:333-43.
3. Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996;272:104-7.
4. Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 1992;89:6901-5.
5. Mazanec MB, Coudret CL, Fletcher DR. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 1995;69;1339-43.
6. McGhee JR, Kiyono H. New perspectives in vaccine development: mucosal immunity to infections. Infect Agents Dis 1993;2:55-73.
7. Staats HF, Jackson RJ, Marinaro M, Takahashi I, Kiyono H, McGhee JR. Mucosal immunity to infection with implications for vaccine development. Curr Opin Immunol 1994;6:572-83.
8. Feng N, Burns JW, Bracy L, Greenberg HB. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol 1994;68:7766-73.
9. Liew FY, Russell SM, Appleyard G, Beale J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol 1984;14:350-6.
10. Renegar KB, Small PA. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J Virol 1991;65:2146-8.
11. Eis-Hubinger AM, Schmidt DS, Schneweis KE. Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J Gen Virol 1993;74:379-85.
12. Whaley KJ, Zeitlin L, Barratt RA, Hoen TE, Cone RA. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections. J Infect Dis 1994;169:647-9.
13. Gallichan WS, Rosenthal KL. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virology 1996;224:487-97.
14. McDermott MR, Goldsmith CH, Rosenthal KL, Brais LJ. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. J Infect Dis 1989;159:460-6.
15. Brandtzaeg P. Overview of the mucosal immune system. Curr Top Microbiol Immunol 1989;146:13-25.